Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.67 |
| ▸ | ESR1 | P03372 | 2/20 | 0.56 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 6/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | MAOB | P27338 | 6/20 | 0.44 |
| ▸ | MAOA | P21397 | 5/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6141654 | 1.00 | CYP3A4 (0.67) | CYP3A4TDP1ESR1ESR2TSHR | |
| SCHEMBL8835571 | 0.88 | MEN1 (0.57) | CYP3A4TDP1ESR1ESR2TSHR | |
| SCHEMBL10385019 | 0.87 | MAOA (0.68) | CYP3A4TDP1ESR1ESR2TSHR | |
| SCHEMBL16094788 | 0.85 | TDP1 (0.92) | CYP3A4TDP1ESR1ESR2TSHR | |
| SCHEMBL1301471 | 0.85 | TDP1 (0.92) | CYP3A4TDP1ESR1ESR2TSHR | |
| Bromide SCHEMBL11573188 | 0.82 | TDP1 (0.86) | CYP3A4TDP1ESR1ESR2TSHR | |
| Hydrochloric Acid SCHEMBL2018015 | 0.82 | TDP1 (0.86) | CYP3A4TDP1ESR1ESR2TSHR | |
| SCHEMBL5028587 | 0.82 | TDP1 (1.00) | CYP3A4TDP1ESR1ESR2TSHR | |
| SCHEMBL101 | 0.82 | TDP1 (1.00) | CYP3A4TDP1ESR1ESR2TSHR | |
| Benzene SCHEMBL6890099 | 0.82 | TDP1 (1.00) | CYP3A4TDP1ESR1ESR2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119978223-A | Preparation method of polymer coating agent for drilling fluid | 濮阳市绿色奇点新材料有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119080832-A | Tetraphosphine ligand complex and preparation method and application thereof | 四川大学 | 2024-12-06 | — | — | CN | claimed |
| CN-119978223-A | Preparation method of polymer coating agent for drilling fluid | 濮阳市绿色奇点新材料有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-119080832-A | Tetraphosphine ligand complex and preparation method and application thereof | 四川大学 | 2024-12-06 | — | — | CN | disclosed |
| EP-3802554-B1 | METHOD FOR SOLUTION-PHASE PEPTIDE SYNTHESIS AND PROTECTING STRATEGIES THEREFORE | SEDERMA SA (FR) | 2023-12-13 | — | — | EP | disclosed |
| CN-114085247-B | Method for preparing linear dihydric alcohol by bidentate phosphine ligand, hydroformylation catalyst and unsaturated fatty acid | 万华化学集团股份有限公司 | 2023-10-17 | — | — | CN | disclosed |
| CN-115850187-B | Organic electroluminescent material based on dibenzo-xenoimidazole derivative, preparation method and application thereof | 季华实验室 | 2023-06-06 | — | — | CN | disclosed |
| CN-115850187-A | Organic electroluminescent material based on dibenzenesulfenimidazole derivative, preparation method and application thereof | 季华实验室 | 2023-03-28 | — | — | CN | disclosed |
| CN-114085247-A | Bidentate phosphine type ligand, hydroformylation catalyst and method for preparing linear dihydric alcohol from unsaturated fatty acid | 万华化学集团股份有限公司 | 2022-02-25 | — | — | CN | disclosed |
| WO-2020159837-A1 | SYNTHESIS STRATEGY FOR GAP PROTECTING GROUP | GAP PEPTIDES LLC (US) | 2020-08-06 | — | — | WO | disclosed |
| US-9029492-B2 | Superconducting electrolytic hybrid material, and preparation method and uses thereof | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2015-05-12 | — | — | US | disclosed |
| EP-2262728-B1 | SULFONE HYBRID PRECURSOR, METHOD OF SYNTHESIZING SAME, AND USES THEREOF | CENTRE NAT RECH SCIENT (FR) | 2014-06-25 | — | — | EP | disclosed |
| EP-2268719-B1 | SUPERCONDUCTING ELECTROLYTIC HYBRID MATERIAL, AND PREPARATION METHOD AND USES THEREOF | CENTRE NAT RECH SCIENT (FR) | 2013-10-23 | — | — | EP | disclosed |
| US-8357817-B2 | Sulfone hybrid precursor, method of synthesizing same, and uses thereof | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2013-01-22 | — | — | US | disclosed |
| US-20110190526-A1 | SULFONE HYBRID PRECURSOR, METHOD OF SYNTHESIZING SAME, AND USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2011-08-04 | — | — | US | disclosed |
| US-20110159406-A1 | SUPERCONDUCTING ELECTROLYTIC HYBRID MATERIAL, AND PREPARATION METHOD AND USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2011-06-30 | — | — | US | disclosed |
| EP-2268719-A2 | SUPERCONDUCTING ELECTROLYTIC HYBRID MATERIAL, AND PREPARATION METHOD AND USES THEREOF | Centre National de la Recherche Scientifique (FR) | 2011-01-05 | — | — | EP | disclosed |
| EP-2262728-A1 | SULFONE HYBRID PRECURSOR, METHOD OF SYNTHESIZING SAME, AND USES THEREOF | Centre National de la Recherche Scientifique (FR) | 2010-12-22 | — | — | EP | disclosed |
| WO-2009125084-A2 | SUPERCONDUCTING ELECTROLYTIC HYBRID MATERIAL, AND PREPARATION METHOD AND USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2009-10-15 | — | — | WO | disclosed |
| WO-2009122043-A1 | SULFONE HYBRID PRECURSOR, METHOD OF SYNTHESIZING SAME, AND USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2009-10-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110190526-A1 | SULFONE HYBRID PRECURSOR, METHOD OF SYNTHESIZING SAME, AND USES THEREOF | STOM, NSF, SDCBP | CYP3A4 3726/4885TDP1 4246/4885ESR1 2219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.